Skip to main content
SpringerLink
Log in

Gonadal Dysfunction and Fertility Preservation in Hodgkin Lymphoma Patients

  • Chapter
  • First Online:
Hodgkin Lymphoma

Part of the book series: Hematologic Malignancies ((HEMATOLOGIC))

  • 1584 Accesses

Abstract

Patients with Hodgkin lymphoma (HL) are generally young, and high cure rates can be achieved. Thus, HL diagnosis and therapy frequently occur at a time of life when family planning plays an important role. It is therefore of major importance for the patients to discuss this subject and to consider fertility preservation techniques as early as possible after diagnosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lee SJ et al (2006) American society of clinical oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24(18):2917–2931

    Article  PubMed  Google Scholar 

  2. Rueffer U et al (2001) Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Ann Oncol 12(9):1307–1311

    Article  CAS  PubMed  Google Scholar 

  3. Sieniawski M et al (2008) Assessment of male fertility in patients with Hodgkin’s lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials. Ann Oncol 19(10):1795–1801

    Article  CAS  PubMed  Google Scholar 

  4. Viviani S et al (1991) Testicular dysfunction in Hodgkin’s disease before and after treatment. Eur J Cancer 27(11):1389–1392

    Article  CAS  PubMed  Google Scholar 

  5. Agarwal A, Allamaneni SS (2005) Disruption of spermatogenesis by the cancer disease process. J Natl Cancer Inst Monogr 34:9–12

    Article  PubMed  Google Scholar 

  6. Barr RD, Clark DA, Booth JD (1993) Dysspermia in men with localized Hodgkin’s disease. A potentially reversible, immune-mediated disorder. Med Hypotheses 40(3):165–168

    Article  CAS  PubMed  Google Scholar 

  7. Dousset B et al (1997) Seminal cytokine concentrations (IL-1beta, IL-2, IL-6, sR IL-2, sR IL-6), semen parameters and blood hormonal status in male infertility. Hum Reprod 12(7):1476–1479

    Article  CAS  PubMed  Google Scholar 

  8. Huleihel M et al (1996) Distinct expression levels of cytokines and soluble cytokine receptors in seminal plasma of fertile and infertile men. Fertil Steril 66(1):135–139

    CAS  PubMed  Google Scholar 

  9. Redman JR et al (1987) Semen cryopreservation and artificial insemination for Hodgkin’s disease. J Clin Oncol 5(2):233–238

    CAS  PubMed  Google Scholar 

  10. Chapman R, Sutcliffe S, Malpas J (1981) Male gonadal dysfunction in Hodgkin’s disease. A prospective study. JAMA 245(13):p1323–p1328

    Article  Google Scholar 

  11. Kreuser E et al (1992) Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin’s disease. Ann Oncol 3(Suppl 4):105–110

    Article  PubMed  Google Scholar 

  12. Kreuser ED et al (1987) Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin’s disease. J Cancer Res Clin Oncol 113(3):260–266

    Article  CAS  PubMed  Google Scholar 

  13. Viviani S et al (1985) Gonadal toxicity after combination chemotherapy for Hodgkin’s disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 21(5):p601–p605

    Article  Google Scholar 

  14. Waxman J et al (1982) Gonadal function in Hodgkin’s disease: long-term follow-up of chemotherapy. Br Med J (Clin Res Ed) 285(6355):1612–1613

    Article  CAS  Google Scholar 

  15. Andrieu J et al (1981) Male fertility in Hodgkin’s disease before and after chemotherapy (author’s transl). Nouv Presse Med 10(25):2085–2088

    CAS  PubMed  Google Scholar 

  16. da Cunha MF et al (1984) Recovery of spermatogenesis after treatment for Hodgkin’s disease: limiting dose of MOPP chemotherapy. J Clin Oncol 2(6):571–577

    PubMed  Google Scholar 

  17. Bonadonna G et al (1984) Gonadal damage in Hodgkin’s disease from cancer chemotherapeutic regimens. Arch Toxicol Suppl 7:140–145

    Article  CAS  PubMed  Google Scholar 

  18. Kulkarni S et al (1997) Gonadal function following ABVD therapy for Hodgkin’s disease. Am J Clin Oncol 20(4):354–357

    Article  CAS  PubMed  Google Scholar 

  19. Gandini L et al (2003) Testicular cancer and Hodgkin’s disease: evaluation of semen quality. Hum Reprod 18(4):796–801

    Article  CAS  PubMed  Google Scholar 

  20. Sieniawski M et al (2008) Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG). Blood 111(1):71–76

    Article  CAS  PubMed  Google Scholar 

  21. van der Kaaij MA et al (2007) Gonadal function in males after chemotherapy for early-stage Hodgkin’s lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol 25(19):2825–2832

    Article  PubMed  Google Scholar 

  22. Andersson AM et al (2004) Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men. J Clin Endocrinol Metab 89(6):2873–2879

    Article  CAS  PubMed  Google Scholar 

  23. Bordallo MA et al (2004) Decreased serum inhibin B/FSH ratio as a marker of Sertoli cell function in male survivors after chemotherapy in childhood and adolescence. J Pediatr Endocrinol Metab 17(6):879–887

    Article  CAS  PubMed  Google Scholar 

  24. van Casteren NJ et al (2009) Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer 52(1):108–112

    Article  PubMed  Google Scholar 

  25. Kumanov P et al (2006) Inhibin B is a better marker of spermatogenesis than other hormones in the evaluation of male factor infertility. Fertil Steril 86(2):332–338

    Article  CAS  PubMed  Google Scholar 

  26. van Beek RD et al (2007) Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin’s lymphoma with chemotherapy during childhood. Hum Reprod 22(12):3215–3222

    Article  PubMed  Google Scholar 

  27. Behringer K et al (2013) Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol 31(2):231–239

    Article  CAS  PubMed  Google Scholar 

  28. Kiserud CE et al (2009) Gonadal function in male patients after treatment for malignant lymphomas, with emphasis on chemotherapy. Br J Cancer 100(3):455–463

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Nuver J et al (2005) The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol 23(16):3718–3725

    Article  CAS  PubMed  Google Scholar 

  30. van der Kaaij et al (2014) Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study. Hum Reprod 29(3):525–533

    Article  PubMed  Google Scholar 

  31. Jahnukainen K et al (2012) Autologous ectopic grafting of cryopreserved testicular tissue preserves the fertility of prepubescent monkeys that receive sterilizing cytotoxic therapy. Cancer Res 72:5174–5178

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Familiari G et al (1993) Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin’s disease. Hum Reprod 8(12):2080–2087

    CAS  PubMed  Google Scholar 

  33. Whitehead E et al (1983) The effect of combination chemotherapy on ovarian function in women treated for Hodgkin’s disease. Cancer 52(6):988–993

    Article  CAS  PubMed  Google Scholar 

  34. Schilsky RL et al (1981) Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin’s disease. Am J Med 71(4):552–556

    Article  CAS  PubMed  Google Scholar 

  35. Franchi-Rezgui P et al (2003) Fertility in young women after chemotherapy with alkylating agents for Hodgkin and non-Hodgkin lymphomas. Hematol J 4(2):116–120

    Article  CAS  PubMed  Google Scholar 

  36. Haukvik UK et al (2006) Treatment-related premature ovarian failure as a long-term complication after Hodgkin’s lymphoma. Ann Oncol 17(9):1428–1433

    Article  CAS  PubMed  Google Scholar 

  37. Behringer K et al (2005) Secondary amenorrhea after Hodgkin’s lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin’s Lymphoma Study Group. J Clin Oncol 23(30):7555–7564

    Article  PubMed  Google Scholar 

  38. Andre M et al (1997) Results of three courses of adriamycin, bleomycin, vindesine, and dacarbazine with subtotal nodal irradiation in 189 patients with nodal Hodgkin’s disease (stage I, II and IIIA). Hematol Cell Ther 39(2):59–65

    Article  CAS  PubMed  Google Scholar 

  39. Bonadonna G (1994) Modern treatment of malignant lymphomas: a multidisciplinary approach? The Kaplan Memorial Lecture. Ann Oncol 5(Suppl 2):5–16

    Article  PubMed  Google Scholar 

  40. Brusamolino E et al (2000) Treatment of early-stage Hodgkin’s disease with four cycles of ABVD followed by adjuvant radio-therapy: analysis of efficacy and long-term toxicity. Haematologica 85(10):​1032–1039

    CAS  PubMed  Google Scholar 

  41. Hodgson DC et al (2007) Fertility among female Hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy. Hematol Oncol 25(1):11–15

    Article  PubMed  Google Scholar 

  42. Horning SJ et al (1981) Female reproductive potential after treatment for Hodgkin’s disease. N Engl J Med 304(23):1377–1382

    Article  CAS  PubMed  Google Scholar 

  43. Howell SJ, Shalet SM (2002) Fertility preservation and management of gonadal failure associated with lymphoma therapy. Curr Oncol Rep 4(5):443–452

    Article  PubMed  Google Scholar 

  44. Tsepelidis S et al (2007) Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod 22(7):1837–1840

    Article  CAS  PubMed  Google Scholar 

  45. van Beek RD et al (2007) Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin’s lymphoma during childhood. J Clin Endocrinol Metab 92(10):3869–3874

    Article  PubMed  Google Scholar 

  46. Visser JA et al (2006) Anti-Mullerian hormone: a new marker for ovarian function. Reproduction 131(1):1–9

    Article  CAS  PubMed  Google Scholar 

  47. Wallace WH, Thomson AB, Kelsey TW (2003) The radiosensitivity of the human oocyte. Hum Reprod 18(1):117–121

    Article  CAS  PubMed  Google Scholar 

  48. Wo JY, Viswanathan AN (2009) Impact of radiotherapy on fertility, pregnancy, and neonatal outcomes in female cancer patients. Int J Radiat Oncol Biol Phys 73(5):1304–1312

    Article  PubMed Central  PubMed  Google Scholar 

  49. Demeestere I et al (2007) Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin’s disease. Oncologist 12(12):1437–1442

    Article  PubMed  Google Scholar 

  50. Blumenfeld Z, von Wolff M (2008) GnRH-analogues and oral contraceptives for fertility preservation in women during chemotherapy. Hum Reprod Update 14(6):543–552

    Article  CAS  PubMed  Google Scholar 

  51. Oktay K et al (2007) Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury. Oncologist 12(9):1055–1066

    Article  CAS  PubMed  Google Scholar 

  52. Del Mastro L et al (2014) Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: Systematic review and meta-analysis of randomized trials. Cancer Treat Rev 40(5):675-683. doi: 10.1016/j.ctrv.2013.12.001. [Epub 2013 Dec 8].

    Article  CAS  PubMed  Google Scholar 

  53. Zhang Y et al (2013) Gonadotropin-releasing hormone for preservation of ovarian function during chemotherapy in lymphoma patients of reproductive age: a summary based on 434 patients. PLoS One 28:8(11)

    Google Scholar 

  54. Behringer K et al (2010) No protection of the ovarian follicle pool with the use of GnRH-analogues or oral contraceptives in young women treated with escalated BEACOPP for advanced-stage Hodgkin lymphoma. Final results of a phase II trial from the German Hodgkin Study Group. Ann Oncol 21(10):2052–2060

    Article  CAS  PubMed  Google Scholar 

  55. Behringer K et al (2012) Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Ann Oncol 23(7):​1818–1825

    Article  CAS  PubMed  Google Scholar 

  56. von Wolff M et al (2009) Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase. Fertil Steril 92(4):1360–1365

    Article  Google Scholar 

  57. Rienzi L et al (2010) Embryo development of fresh ‘versus’ vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum Reprod 25:66–73

    Article  PubMed Central  PubMed  Google Scholar 

  58. Donnez J et al (2013) Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertil Steril 99(6):1503–1513

    Article  PubMed  Google Scholar 

  59. Shaw JM et al (1996) Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod 11(8):1668–1673

    Article  CAS  PubMed  Google Scholar 

  60. Seshadri T et al (2006) Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield. Br J Cancer 94(7):1007–1010

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Byrne J (1999) Infertility and premature menopause in childhood cancer survivors. Med Pediatr Oncol 33(1):24–28

    Article  CAS  PubMed  Google Scholar 

  62. Larsen EC et al (2003) Reduced ovarian function in long-term survivors of radiation-and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab 88(11):5307–5314

    Article  CAS  PubMed  Google Scholar 

  63. Sklar CA et al (2006) Premature menopause in survivors of childhood cancer: a report from the childhood cancer survivor study. J Natl Cancer Inst 98(13):​890–896

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Internal Medicine, German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany

    Karolin Behringer

  2. Department of Gynecological Endocrinology and Reproductive Medicine, University Hospital – Inselspital Berne, Berne, Switzerland

    Michael von Wolff

Authors
  1. Karolin Behringer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael von Wolff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karolin Behringer .

Editor information

Editors and Affiliations

  1. Universitätsklinikum Köln Klinik I für Innere Medizin, Köln, Germany

    Andreas Engert

  2. Memorial Sloan - Kettering Cancer Center, New York, New York, USA

    Anas Younes

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing

About this chapter

Cite this chapter

Behringer, K., von Wolff, M. (2015). Gonadal Dysfunction and Fertility Preservation in Hodgkin Lymphoma Patients. In: Engert, A., Younes, A. (eds) Hodgkin Lymphoma. Hematologic Malignancies. Springer, Cham. https://doi.org/10.1007/978-3-319-12505-3_26

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-12505-3_26

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-12504-6

  • Online ISBN: 978-3-319-12505-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation